In the News
In the News
Treatment Recommendation for Diabetic Foot Ulcers (DFUs) by the Wound Healing Society
AOTI's at-home TWO2® therapy is able to deliver oxygen topically into chronic wounds, including DFUs, and to encourage high-quality, durable wound healing OCEANSIDE, Calif., Dec. 4, 2023 /PRNewswire/ -- AOTI Inc., the global leader in multimodality topical wound...
AOTI to Present Keynote at Advanced Wound Care Summit Europe
Dr. Mike Griffiths to lead discussions on durable wound healing at summit dedicated to advancing commercialization of cutting-edge wound care products OCEANSIDE, Calif., Nov. 27, 2023 /PRNewswire/ -- AOTI Inc., the global leader in multimodality topical wound oxygen...
AOTI Participates in Panel Discussion at Preventing Diabetes-Related Amputations in America
OCEANSIDE, Calif., July 14, 2023 /PRNewswire/ -- AOTI Inc., the global leader in multimodality topical wound oxygen therapy, participated as a founding member of the Amputation Prevention Alliance (APA), in the "Preventing Diabetes-Related Amputations in America: A...
The Most Positive Thing to Happen to Negative Pressure Wound Therapy
OCEANSIDE, Calif., June 7, 2023 /PRNewswire/ -- AOTI Inc, the global leader in multi-modality topical wound oxygen, announced exciting news from ongoing WOCNext conference in Las Vegas, Nevada, where their game changing NEXA Negative Pressure Wound Therapy (NPWT)...
Topical Oxygen Therapy Awarded Positive Treatment Recommendation by the International Working Group on the Diabetic Foot in their 2023 Diabetic Foot Ulcer Guidelines
AOTI Inc, the global leader in multi-modality topical wound oxygen, announced exciting news from the 9th International Symposium on the Diabetic Foot (ISDF). The IWGDF has recognized the efficacy of topical oxygen therapy in their 2023 Diabetic Foot Ulcer Guidelines, further endorsing AOTI Inc.’s innovative treatment approach.
Topical Oxygen Therapy Awarded “A” Grade Treatment Recommendation by the American Diabetes Association in their 2023 Standards of Care in Diabetes
OCEANSIDE, Calif., Dec. 13, 2022 /PRNewswire/ -- Advanced Oxygen Therapy Inc. (AOTI), the global leader in noninvasive topical oxygen wound healing solutions, announced today that the American Diabetes Association has awarded an "A" grade recommendation for utilizing...
AOTI Receives China FDA Approval for Topical Wound Oxygen (TWO2) Therapy Providing Renewed Hope for World’s Largest Diabetic Foot Ulcer Population
OCEANSIDE, Calif., March 23, 2022 /PRNewswire/ -- Advanced Oxygen Therapy Inc. (AOTI), the global leader in noninvasive topical oxygen wound healing solutions, announced today that is has received Chinese National Medical Products Administration (NMPA), commonly...
Announcing Key Leadership Team Additions and Scientific Clinical Advisory Board Formation
OCEANSIDE, Calif., Feb. 14, 2022 /PRNewswire/ -- Advanced Oxygen Therapy Inc. (AOTI), the leader in noninvasive sustained wound healing solutions, announced today a number of significant additions to its Leadership Team, bringing to the company over 100 years of...
Durable Healing Outcomes of Topical Wound Oxygen (TWO2) Therapy Highlighted at Leading International Clinical Conferences
OCEANSIDE, Calif., Aug. 26, 2021 /PRNewswire/ -- Advanced Oxygen Therapy Inc. (AOTI) announced today that its unique multimodality Topical Wound Oxygen (TWO2) therapy was recently highlighted at multiple leading international clinical conferences across the United...